1	Amgen	NNP	2	nn
2	Inc.	NNP	3	nsubj
3	said	VBD	0	root
4	its	PRP$	6	poss
5	second-quarter	JJ	6	amod
6	earnings	NNS	7	nsubj
7	increased	VBD	3	ccomp
8	more	RBR	9	advmod
9	than	IN	7	advmod
10	tenfold	RB	9	advmod
11	to	TO	7	prep
12	$	$	11	pobj
13	3.9	CD	12	number
14	million	CD	12	number
15	,	,	12	punct
16	or	CC	12	cc
17	22	CD	18	num
18	cents	NNS	12	conj
19	a	DT	20	det
20	share	NN	18	npadvmod
21	,	,	7	punct
22	due	JJ	7	prep
23	to	TO	22	prep
24	increased	VBN	25	amod
25	sales	NNS	23	pobj
26	of	IN	25	prep
27	the	DT	28	det
28	company	NN	32	poss
29	's	POS	28	possessive
30	new	JJ	32	amod
31	antianemia	JJ	32	amod
32	drug	NN	26	pobj
33	for	IN	32	prep
34	kidney	NN	35	nn
35	patients	NNS	33	pobj
36	.	.	3	punct

1	The	DT	7	det
2	Thousand	NNP	5	amod
3	Oaks	NNP	5	amod
4	,	,	5	punct
5	Calif.-based	JJ	7	amod
6	biotechnology	NN	7	nn
7	company	NN	8	nsubj
8	reported	VBD	0	root
9	a	DT	12	det
10	97	CD	11	number
11	%	NN	12	amod
12	increase	NN	8	dobj
13	in	IN	12	prep
14	revenue	NN	13	pobj
15	to	TO	12	prep
16	$	$	15	pobj
17	42.5	CD	16	number
18	million	CD	16	number
19	for	IN	8	prep
20	the	DT	21	det
21	quarter	NN	19	pobj
22	ended	VBN	21	partmod
23	Sept.	NNP	22	tmod
24	30	CD	23	num
25	.	.	8	punct

1	In	IN	7	prep
2	the	DT	4	det
3	year-ago	JJ	4	amod
4	period	NN	1	pobj
5	,	,	7	punct
6	Amgen	NNP	7	nsubj
7	reported	VBD	0	root
8	net	JJ	9	amod
9	income	NN	7	dobj
10	of	IN	9	prep
11	$	$	10	pobj
12	320,000	CD	11	num
13	,	,	11	punct
14	or	CC	11	cc
15	two	CD	16	num
16	cents	NNS	11	conj
17	a	DT	18	det
18	share	NN	16	npadvmod
19	,	,	9	punct
20	on	IN	9	prep
21	revenue	NN	20	pobj
22	of	IN	21	prep
23	$	$	22	pobj
24	21.5	CD	23	number
25	million	CD	23	number
26	.	.	7	punct

1	For	IN	8	prep
2	the	DT	4	det
3	six	CD	4	num
4	months	NNS	1	pobj
5	,	,	8	punct
6	the	DT	7	det
7	company	NN	8	nsubj
8	reported	VBD	0	root
9	a	DT	13	det
10	more	JJR	11	dep
11	than	IN	13	advmod
12	sixfold	JJ	11	advmod
13	increase	NN	8	dobj
14	in	IN	13	prep
15	earnings	NNS	14	pobj
16	to	TO	13	prep
17	$	$	16	pobj
18	4.7	CD	17	number
19	million	CD	17	number
20	,	,	17	punct
21	or	CC	17	cc
22	26	CD	23	num
23	cents	NNS	17	conj
24	a	DT	25	det
25	share	NN	23	npadvmod
26	,	,	13	punct
27	from	IN	13	prep
28	$	$	27	pobj
29	625,000	CD	28	num
30	,	,	28	punct
31	or	CC	28	cc
32	four	CD	33	num
33	cents	NNS	28	conj
34	a	DT	35	det
35	share	NN	33	npadvmod
36	a	DT	37	det
37	year	NN	38	npadvmod
38	ago	RB	27	advmod
39	.	.	8	punct

1	Revenue	NN	2	nsubj
2	rose	VBD	0	root
3	77	CD	4	num
4	%	NN	2	dobj
5	to	TO	2	prep
6	$	$	5	pobj
7	72.6	CD	6	number
8	million	CD	6	number
9	,	,	2	punct
10	from	IN	2	prep
11	last	JJ	12	amod
12	year	NN	10	pobj
13	's	POS	12	possessive
14	$	$	12	num
15	41	CD	14	number
16	million	CD	14	number
17	.	.	2	punct


